학술논문
118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)
Document Type
Abstract
Author
Melero, I.; De Miguel, M.J.; Casal, G. Alonso; De Velasco Oria, G.A.; Ramelyte, E.; Joerger, M.; Martin-Liberal, J.; König, D.; Sayehli, C.M.; Gromke, T.; RodrÍguez-Ruiz, M.E.; Calvo, E.; Garralda, E.; Soto-Castillo, J.J.; Dummer, R.; Villarrubia, J. Esteban; Goebeler, M-E.; Fettes, P.; Klar, K.; Leo, E.
Source
In Immuno-Oncology and Technology December 2023 20 Supplement
Subject
Language
ISSN
2590-0188